Zhi Zhang

Title: Zhi Zhang - Innovator in Dendrimer Delivery Systems

Introduction

Zhi Zhang is a prominent inventor based in Towson, MD (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on dendrimer formulations. His research focuses on developing methods that enhance the delivery of therapeutic agents to treat various diseases.

Latest Patents

Zhi Zhang holds 1 patent for a "Dendrimer delivery system and methods of use thereof." This patent describes low-generation dendrimers that contain a high density of surface hydroxyl groups. Specifically, it details oligo ethylene glycol (OEG)-like dendrimers with a high number of surface functional groups at relatively low generations, such as approximately 120 hydroxyls in the third generation, with a size of just 1-2 nm. The patent also outlines dendrimer formulations that include one or more prophylactic, therapeutic, and/or diagnostic agents, suitable for various delivery methods to treat diseases, particularly those affecting the eye and central nervous system.

Career Highlights

Zhi Zhang is affiliated with The Johns Hopkins University, where he continues to advance his research in dendrimer technology. His work has the potential to significantly impact the treatment of conditions associated with pathological activation of microglia and astrocytes.

Collaborations

Zhi Zhang collaborates with notable colleagues, including Kannan Rangaramanujam and Rishi Sharma, to further enhance the scope and application of his research.

Conclusion

Zhi Zhang's innovative work in dendrimer delivery systems exemplifies the potential of advanced drug delivery technologies. His contributions are paving the way for new therapeutic approaches in medicine.